Paclitaxel-coated versus standard dilatation balloon for recurrent urethral stricture
Official title: Risk of Recurrent Urethral Stricture After Treatment With Paclitaxel-Coated Dilatation Balloon (Optilume) Compared With Non-coated Dilatation Balloon - a Prospective Randomised Multicentre Study
Run by Vastra Gotaland Region · NCT06795074 · Data updated 2026-11-12
This trial tests if a paclitaxel-coated dilatation balloon (Optilume) reduces the chance of urethral stricture coming back compared with a non-coated balloon in adults who have had previous dilations or DVIU.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 230 (estimated) |
| Sponsor | Vastra Gotaland Region Government |
| Drugs / interventions | radiation |
| Locations | 4 sites (Gothenburg and 3 other locations) |
| Status | Recruiting |
| Started | January 16, 2026 |
| Main results expected | February 2029 |
| Study ends | February 2031 |
| Registry record updated | January 16, 2026 |
| Trial ID | NCT06795074 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 or older with a recurrent penile or bulbar urethral stricture ≤2 cm after at least one internal urethrotomy or dilation who are eligible for urethroplasty.
✕Probably not a fit
Patients with complete strictures without any lumen, meatal strictures, multiple small-caliber strictures, prior paclitaxel-coated balloon treatment, prior pelvic radiation, prior pelvic fracture, urethral malignancy, fistula, condyloma, previous open urethroplasty, or chronic urinary retention from detrusor inactivity are unlikely to benefit from the balloon treatment in this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a phase 4, randomized comparison of a paclitaxel-coated dilatation balloon (Optilume) versus a non-coated dilatation balloon (UroMax Ultra) for adults with recurrent penile or bulbar urethral strictures up to 2 cm. Eligible participants have had at least one prior internal urethrotomy or dilation and are candidates for open urethroplasty; key exclusions include complete strictures without a lumen, prior pelvic radiation, prior paclitaxel balloon dilation, and prior open urethroplasty. The trial is conducted at multiple university hospitals in Sweden and measures the risk of stricture recurrence after treatment with either device. Follow-up visits are required to monitor for recurrence and complications.
Why it matters
Potential benefit: If successful, this could lower recurrence rates and help patients avoid or delay open urethroplasty.
How similar studies have gone: Paclitaxel-coated urethral balloons like Optilume have CE marking and prior industry-sponsored randomized trials (for example ROBUST III) have shown promising results, though independent long-term evidence is still limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 18 years * Urethral stricture recurrence after at least one internal urethrotomy or dilatation * Penile or bulbar stricture * Length of stricture ≤ 2 cm * Eligible for open urethroplasty * Able to give informed consent Exclusion Criteria: * Stricture of the meatus * Sclerosis of the bladder neck * Multiple strictures \< 16 Ch * Complete stricture without any lumen * Previous dilatation with paclitaxel-coated balloon * Previous radiation therapy of the pelvis (e.g. for prostate cancer) * Previous pelvic fracture * Urethral malignancy * Presence of urethral fistula * Presence of urethral condyloma * Previous open urethroplasty * Chronic urinary retention secondary to detrusor inactivity
Where it's running
-
Sahlgrenska University Hospital
Gothenburg, Sweden Recruiting -
Skåne University Hospital
Malmö, Sweden Not yet recruiting -
Örebro University Hospital
Örebro, Sweden Not yet recruiting -
Karolinska University Hospital
Stockholm, Sweden Not yet recruiting
Study contacts
- Study coordinator: Henrik Kjölhede, MD, PhD
- Email: henrik.kjolhede@vgregion.se
- Phone: +46-31-3421000
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Intraoperative Lidocaine or Dexmedetomidine to Help Postoperative Pain After Urethral Reconstruction
This study tests whether giving lidocaine or dexmedetomidine during urethral reconstruction can reduce pain after surgery and lower the chance of long-lasting pain.
-
Urethral Resistive Index (URI) as a non-invasive test for urethral blockage
This project tests a new, painless urine-flow measure called the Urethral Resistive Index (URI) to see if it can detect urethral strictures in men.
-
Comparing cheek (buccal) tissue versus penile skin grafts for repairing long anterior urethral strictures
This will test whether cheek (buccal) tissue or penile skin works better to repair long anterior urethral strictures in men who need urethroplasty.
-
Database for patients with urethral stricture undergoing surgery
This study is trying to gather information from patients with urethral stricture who are having surgery to see how well different surgical methods work and how they affect quality of life.
-
Study on urethroplasty for urethral stricture disease
This study is testing how well urethroplasty works for treating urethral stricture disease in different groups of people, including men, women, transgender individuals, and children.
-
Using engineered urethral constructs to treat urethral strictures in men
This study is testing a new way to treat urethral strictures in men by using specially grown tissue from their own bladder to see if it helps them feel better over time.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.